Darwin Global Management, Ltd.
- SEC CIK
- 0001839209
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 3
- −1 vs. Q1 2023
- Portfolio value
- $611.7M
- +$246.1M (+67.3%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 16,688,636 | $274.7M | 44.9% | +5,384,063+47.6% | Added | History |
| TGTXTG Therapeutics, Inc. | COM | 9,278,439 | $230.5M | 37.7% | −1,172,802−11.2% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 273,343 | $106.5M | 17.4% | −11,855−4.2% | Reduced | History |
Sold out since Q1 2023 (1)
Positions held at the end of Q1 2023 that are gone from this filing.